4-methoxyamphetamine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, MA; Campbell-Thompson, M; Clarke, T; Croker, B; Glushakova, O; Heinig, M; Johnson, RJ; Nakagawa, T; Sato, W; Yuzawa, Y | 1 |
| Gajdosík, A; Gajdosíková, A; Hozová, R; Navarová, J; Stefek, M | 1 |
2 other study(ies) available for 4-methoxyamphetamine and Alloxan Diabetes
| Article | Year |
|---|---|
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
Topics: Animals; Death; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Insulin; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Vascular Endothelial Growth Factor A | 2007 |
Streptozotocin-induced experimental diabetes in male Wistar rats.
Topics: Animals; Blood Glucose; Body Weight; Death; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drinking Behavior; Feeding Behavior; Male; Organ Size; Rats; Rats, Wistar; Streptozocin | 1999 |